Literature DB >> 33482824

Potential diagnostic and prognostic value and regulatory relationship of long noncoding RNA CCAT1 and miR-130a-3p in clear cell renal cell carcinoma.

Jingjing Jing1, Xu Zhao2, Jiannan Wang3, Tan Li4.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) could interact with each other to play a vital role in the pathogenesis of cancers. We aimed to examine the expression profile, clinical significance and regulatory relationship of miR-130a-3p and its predicted interactive lncRNA in clear cell renal cell carcinoma (ccRCC).
METHODS: Bioinformatics analysis was used to predict lncRNAs binding with miR-130a-3p. qRT-PCR was employed to detect the expression levels of miR-130a-3p and the miRNA-targeted lncRNA, and their clinical values in ccRCC were clarified. The lncRNA sponge potential of miR-130a-3p was assessed through dual-luciferase reporter assay and the biological effects of them were observed.
RESULTS: Colon cancer associated transcript 1 (CCAT1) directly interacted with miR-130a-3p and negatively regulated miR-130a-3p expression. CCAT1 was upregulated and miR-130a-3p was downregulated in ccRCC cell line and tissues (all P < 0.05). High CCAT1 and low miR-130a-3p expression was correlated with larger tumor size and advanced TNM stage in ccRCC patients. High CCAT1 level suggested a poor survival prognosis. There was a negative association between CCAT1 and miR-130a-3p expression (r = - 0.373, P = 0.010). MiR-130a-3p mimic and si-CCAT1 inhibited ccRCC cell proliferation and invasion, and induced apoptosis.
CONCLUSIONS: CCAT1/miR-130a-3p axis may have potential to serve as a novel diagnostic and prognostic target of ccRCC patients.

Entities:  

Keywords:  Biological effect; CCAT1; Expression; ccRCC; miR-130a-3p

Year:  2021        PMID: 33482824     DOI: 10.1186/s12935-021-01757-7

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  3 in total

1.  LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.

Authors:  X-J Lai; H-F Cheng
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-01       Impact factor: 3.507

2.  Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.

Authors:  Xin-Feng Zhang; Ting Liu; Yang Li; Su Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration.

Authors:  Jing Yu; Lijuan Jiang; Yutao Gao; Qijian Sun; Beibei Liu; Yong Hu; Xuesong Han
Journal:  Exp Ther Med       Date:  2019-03-20       Impact factor: 2.447

  3 in total
  1 in total

1.  Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.

Authors:  Sheng Xue; Hanxu Guo; Shibo Wei; Yuan Song; Junfeng Huang; Shuo Deng; Qingwen Li; Wenyong Li
Journal:  Transl Androl Urol       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.